| |
| Magyar Kardiológusok Társasága |
|
| The 1st Budapest Symposium on Atrial Fibrillation |
 Rendezvény kezdete: 2006.04.06. | Rendezvény vége: 2006.04.07. |
| Helyszín: Budapest, Hilton Budapest WestEnd Hotel |
Organized by the Hungarian Institute of Cardiology
Welcome to Budapest
On behalf of the Programme Committee and the Local Organizing Committee of the 1st Budapest Symposium on Atrial Fibrillation we are delighted to invite you to Budapest on the 06-07th of April 2006.
The Hungarian Institute of Cardiology is honoured to be the host of the Atrial Fibrillation Symposium and to provide a forum for delegates to learn together, share experiences, strengthen links and explore collaborative approaches in the treatment of Atrial Fibrillation.
The social dinner – cruising on the Danube – will get you acquainted with the splendid panorama of the two banks of the river, while the conference venue is fulfilling all requirements needed for a successful meeting.
Tamas Szili-Torok, MD, PhD Scientific Organizer
Csaba Foldesi, MD Associate Organizer
Conference Bureau
Convention Budapest Ltd.
Máté Lukácsi project manager
Pf. 11, 1461 Budapest, Hungary
Phone: + 36 1 299 0184, -85, -86
Fax: + 36 1 299 0187
e-mail: mlukacsi@convention.hu
The preliminary program of the conference and more information are available on the following web-site: http://www.convention.hu/db/display.php?id=79 |
|
|
 |
| |
| Magyar Kardiológusok Társasága |
|
| International Conference on Early Disease Detection and Prevention (EDDP) |
| Rendezvény kezdete: 2010.02.25. | Rendezvény vége: 2010.02.28. |
| Helyszín: Németország, München, |
| A rendezvény Web oldala: http://www.paragon-conventions.com/EDDP2010 |
This year's EDDP conference will focus on cardiovascular (cardiac disease and hypertension), metabolic (diabetes) and renal diseases. With a scientific program featuring a distinguished international panel of leading speakers, as well as a concurrent exhibition, this conference aims to:
Discuss all elements relevant to early detection of disease prior to its clinical appearance
Highlight the most updated technological and other means for disease prevention
Encourage a free exchange of ideas among high-caliber presenters and participants
Serve as a platform for the biotech/pharma industries to discuss ongoing projects and products
Present general principles, ongoing academic/industrial research, and the latest achievements in the field
Highlight biotechnological innovations and evaluate their applicability and cost-effectiveness
Set the stage for prevention of disease by pharmacological, genetic or other interventional modalities |
|
|
|
